Published in Arch Dis Child on December 01, 1994
Cloning and expression of the human erythropoietin gene. Proc Natl Acad Sci U S A (1985) 3.28
Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease. N Engl J Med (1993) 2.50
A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia. Blood (1993) 2.29
Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med (1989) 2.13
Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation. N Engl J Med (1993) 2.09
Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med (1990) 1.89
Cytokine treatment of inherited bone marrow failure syndromes. Blood (1993) 1.60
Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med (1987) 1.55
A radioimmunoassay for erythropoietin. Blood (1979) 1.21
Differential effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in children with severe congenital neutropenia. Blood (1990) 1.12
Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion (1993) 1.05
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation. Blood (1990) 0.97
Placebo-controlled phase III trial of lenograstim in bone-marrow transplantation. Lancet (1994) 0.94
Effects of recombinant human interleukin-3 in patients with myelodysplastic syndromes. Blood (1990) 0.92
Congenital agranulocytosis terminating in acute myelomonocytic leukemia. J Pediatr (1979) 0.88
In vitro enhancement of erythropoiesis by steel factor in Diamond-Blackfan anemia and treatment of other congenital cytopenias with recombinant interleukin 3/granulocyte-macrophage colony stimulating factor. Stem Cells (1993) 0.86
Correction of infantile agranulocytosis (Kostmann's syndrome) by allogeneic bone marrow transplantation. Am J Med (1980) 0.85
In vitro functions of neutrophils induced by treatment with rhG-CSF in severe congenital neutropenia. Eur J Haematol (1991) 0.84
Indications and guidelines for the use of hematopoietic growth factors. Transfusion (1994) 0.82
Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia. Bone Marrow Transplant (1994) 0.81
Treatment of aplastic anemia in children with recombinant human granulocyte colony-stimulating factor. Blood (1991) 0.80
Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. Am J Med (1989) 0.80
Effects of interleukin-3 and granulocyte-macrophage colony-stimulating factor on thrombopoiesis in congenital amegakaryocytic thrombocytopenia. Blood (1993) 0.79
Therapeutic effects and pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in childhood cancer patients receiving myelosuppressive chemotherapy. J Clin Oncol (1991) 0.79
Serum immunoreactive erythropoietin in patients with idiopathic aplastic and Fanconi's anaemias. Br J Haematol (1992) 0.78
A phase I/II study of sequential interleukin-3 and granulocyte-macrophage colony-stimulating factor in myelodysplastic syndromes. Blood (1994) 0.78
Bone marrow transplantation for constitutional pure red cell aplasia. Blood (1988) 0.78
Efficacy of delayed granulocyte colony-stimulating factor after autologous BMT. Bone Marrow Transplant (1993) 0.78
The treatment of anaemia in the myelodysplastic syndromes with recombinant human erythropoietin. Br J Haematol (1991) 0.77
Improvement in anemia by recombinant human erythropoietin in patients with myelodysplastic syndrome and aplastic anemia. Contrib Nephrol (1991) 0.77
Granulocyte colony-stimulating factor corrects the neutropenia associated with glycogen storage disease type Ib. Leukemia (1991) 0.77
Use of GM-CSF in children after high-dose chemotherapy. Med Pediatr Oncol Suppl (1992) 0.77
Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation. Blood (1993) 0.77
A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia. Blood (1990) 0.77